erythropoetin beta

also known as epoetin-β

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Comparator or background therapy1 trial
Phase 4	NCT00568542 Comparator	May 2006 → Oct 2008	cardiomyopathy	Charite University, Berlin, Germany	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	erythropoetin beta	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00568542 ↗
Known as	epoetin-β	“We performed a randomized, placebo-controlled, double-blind, single-centre study of 35 IU/kg body weight epoetin-β given subcutaneously once weekly for 6 months started within...” PMID 21505058 ↗ May 2011
Route	Subcutaneous	“given subcutaneously once weekly for 6 months” PMID 21505058 ↗ May 2011